ANKRD11 restrains CD8+ T cells in hepatitis B and cancer models
A mouse study found that removing ANKRD11 enhanced CD8+ T-cell activity against chronic hepatitis B virus infection and cancer, but ...
A mouse study found that removing ANKRD11 enhanced CD8+ T-cell activity against chronic hepatitis B virus infection and cancer, but ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine